Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac382Source: DataRank Database

Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection is a research paper published in Open Forum Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.28)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Ting-Yi Chen,Hosoon Choi,Munok Hwang,Dhammika H. Navarathna ORCID,Linhue Hao

Live enrichment

PubMed:36039098 PMC:PMC9384609 OpenAlex:https://openalex.org/W4288686848

NIAID NIH HHS

Grant: U01 AI151698

NIH HHS

Grant: P51 OD010425

National Institutes of Health

Grant: 3U01AI151698-03S2

University of Washington Arboviral Research Network (UWARN)

National Institutes of Health

VASeqCURE

American Rescue Plan

Central Texas Veterans Health Care System

FWCI

3.28

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

goldLicense: public-domain

journalhttps://academic.oup.com/ofid/article-pdf/9/8/ofac382/45601607/ofac382.pdf

publisherhttps://academic.oup.com/ofid/article-pdf/9/8/ofac382/45601607/ofac382.pdf

publisherhttps://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofac382/45189708/ofac382.pdf

journalhttps://doi.org/10.1093/ofid/ofac382

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36039098

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchDrug-Induced Adverse Reactions0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

MedicineCoronavirus disease 2019 (COVID-19)CoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiseaseIntensive care medicineInternal medicineVirologyInfectious disease (medical specialty)OutbreakCt ValuePersistent Covid-19Prolonged RemdesivirRemdesivir MutationRemdesivir ResistanceBrief Report

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being